LABORATORIOS FARMACEUTICOS ROVI, S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 85 EUR | +0.35% |
|
+7.05% | +41.20% |
| Apr. 02 | Spain's Rovi Obtains US FDA Approval for Marketing Risvan as Schizophrenia Treatment | MT |
| Mar. 12 | Rovi, Partners to Form Entity for Advanced Therapies R&D | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 85.07 | 103.39 | 110.38 |
| Spread/Res. | -0.08% | -17.79% | -22.99% |
| Spread/Supp. | +4.17% | +39.00% | +49.78% |
| Support | 81.60 | 61.15 | 56.75 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- ROVI Stock
- Charts Laboratorios Farmaceuticos Rovi, S.A.
